# IHE holdings: all 54 positions

> All 54 IHE holdings with weights, as of Oct 13, 2026. The top 3 are LLY 24.43%, JNJ 21.92% and PFE 4.81%. Download the full list as a CSV.

Data as of Oct 13, 2026. Rebuilt every trading night.

IHE held 54 positions as of Oct 13, 2026. ELI Lilly is the largest at 24.43%; the top 10 are 79.3% of the fund.

Source: iShares (BlackRock) (https://www.ishares.com/us/products/239519/x/latest-holdings.csv).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | ELI Lilly | LLY | 24.43% |
| 2 | Johnson & Johnson | JNJ | 21.92% |
| 3 | Pfizer | PFE | 4.81% |
| 4 | Zoetis Inc Class A | ZTS | 4.77% |
| 5 | Viatris | VTRS | 4.57% |
| 6 | Merck & Co Inc | MRK | 4.53% |
| 7 | Royalty Pharma PLC Class A | RPRX | 4.40% |
| 8 | Bristol Myers Squibb | BMY | 4.14% |
| 9 | Jazz Pharmaceuticals PLC | JAZZ | 3.15% |
| 10 | Corcept Therapeutics | CORT | 2.58% |
| 11 | Elanco Animal Health | ELAN | 2.58% |
| 12 | Axsome Therapeutics | AXSM | 1.61% |
| 13 | Ligand Pharmaceuticals | LGND | 1.40% |
| 14 | Definium Therapeutics Inc | DFTX | 1.07% |
| 15 | Indivior Pharmaceuticals Inc | INDV | 0.96% |
| 16 | Veradermics | MANE | 0.84% |
| 17 | Organon | OGN | 0.83% |
| 18 | Amneal Pharmaceuticals Inc Class A | AMRX | 0.83% |
| 19 | Edgewise Therapeutics | EWTX | 0.68% |
| 20 | Amylyx Pharmaceuticals | AMLX | 0.64% |
| 21 | Tarsus Pharmaceuticals | TARS | 0.63% |
| 22 | Enliven Therapeutics | ELVN | 0.58% |
| 23 | Supernus Pharmaceuticals | SUPN | 0.56% |
| 24 | Prestige Consumer Healthcare | PBH | 0.53% |
| 25 | Perrigo PLC | PRGO | 0.49% |
| | USD Cash | | 0.06% |
| | BLK Csh Fnd Treasury Sl Agency | | 0.02% |
| | Cash Collateral Usd Sgaft | | 0.01% |
| | Cash and other net assets | | 0.02% |

The largest 25 of 54 positions are shown. All of them: https://etfiq.com/funds/ihe/holdings/ihe-holdings.csv (CSV) or https://etfiq.com/data/books/ihe.json (JSON).

Fund page: https://etfiq.com/funds/ihe

Cite: ETFIQ, Holdings of IHE, data as of Oct 13, 2026. https://etfiq.com/funds/ihe/holdings/